Early research (Phase 1)Study completedNCT00003462
What this trial is testing
Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors
Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20